JP2011518842A5 - - Google Patents

Download PDF

Info

Publication number
JP2011518842A5
JP2011518842A5 JP2011506485A JP2011506485A JP2011518842A5 JP 2011518842 A5 JP2011518842 A5 JP 2011518842A5 JP 2011506485 A JP2011506485 A JP 2011506485A JP 2011506485 A JP2011506485 A JP 2011506485A JP 2011518842 A5 JP2011518842 A5 JP 2011518842A5
Authority
JP
Japan
Prior art keywords
formulation
galactomannan
diol
cis
borate
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2011506485A
Other languages
English (en)
Japanese (ja)
Other versions
JP5659149B2 (ja
JP2011518842A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2009/041699 external-priority patent/WO2009132294A1/en
Publication of JP2011518842A publication Critical patent/JP2011518842A/ja
Publication of JP2011518842A5 publication Critical patent/JP2011518842A5/ja
Application granted granted Critical
Publication of JP5659149B2 publication Critical patent/JP5659149B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2011506485A 2008-04-26 2009-04-24 ポリマー性人工涙液系 Active JP5659149B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US4817508P 2008-04-26 2008-04-26
US61/048,175 2008-04-26
PCT/US2009/041699 WO2009132294A1 (en) 2008-04-26 2009-04-24 Polymeric artificial tear system

Publications (3)

Publication Number Publication Date
JP2011518842A JP2011518842A (ja) 2011-06-30
JP2011518842A5 true JP2011518842A5 (enExample) 2013-03-14
JP5659149B2 JP5659149B2 (ja) 2015-01-28

Family

ID=40886688

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2011506485A Active JP5659149B2 (ja) 2008-04-26 2009-04-24 ポリマー性人工涙液系

Country Status (17)

Country Link
US (3) US20090270345A1 (enExample)
EP (1) EP2278954B1 (enExample)
JP (1) JP5659149B2 (enExample)
KR (1) KR101592872B1 (enExample)
CN (1) CN102046150B (enExample)
AR (2) AR071834A1 (enExample)
AU (1) AU2009240488B2 (enExample)
BR (1) BRPI0910717A2 (enExample)
CA (1) CA2722508C (enExample)
CL (1) CL2009000985A1 (enExample)
ES (1) ES2818619T3 (enExample)
MX (1) MX2010011736A (enExample)
NZ (1) NZ589323A (enExample)
TW (1) TWI526213B (enExample)
UY (1) UY31785A1 (enExample)
WO (1) WO2009132294A1 (enExample)
ZA (1) ZA201007644B (enExample)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7220431B2 (en) * 2002-11-27 2007-05-22 Regents Of The University Of Minnesota Methods and compositions for applying pharmacologic agents to the ear
US20050137166A1 (en) * 2003-12-19 2005-06-23 Alcon, Inc. Use of cooling agents to relieve mild ocular irritation and enhance comfort
AR071834A1 (es) * 2008-04-26 2010-07-21 Alcon Res Ltd Sistema polimerico de lagrimas artificiales
TWI547522B (zh) 2009-07-07 2016-09-01 愛爾康研究有限公司 環氧乙烷環氧丁烷嵌段共聚物組成物
TWI478730B (zh) * 2009-12-03 2015-04-01 Alcon Res Ltd 眼科乳劑
HUE038821T2 (hu) * 2009-12-03 2018-11-28 Novartis Ag Karboxivinil polimert tartalmazó nanorészecske szuszpenziók
NZ603345A (en) * 2010-05-05 2014-12-24 Alcon Res Ltd Stabilized ophthalmic galactomannan formulations
UA113434C2 (uk) * 2012-05-04 2017-01-25 Алкон Рісерч, Лтд. Офтальмологічна композиція з поліпшеним захистом від зневоднювання й утриманням
US20130344619A1 (en) 2012-06-21 2013-12-26 Lightship Medical Limited Glucose sensor
US11730699B2 (en) 2018-02-21 2023-08-22 Alcon Inc. Lipid-based ophthalmic emulsion
TWI913170B (zh) 2018-02-21 2026-01-21 瑞士商愛爾康公司 基於脂質的眼用乳劑
JP6705495B1 (ja) * 2018-12-26 2020-06-03 株式会社Jvcケンウッド 車両用記録制御装置、車両用記録装置、車両用記録制御方法およびプログラム
US12329763B2 (en) * 2019-03-04 2025-06-17 Guangzhou Ocusun Ophthalmic Biotechnology Co., Ltd. Composition of lanosterol prodrug compound, preparation method therefor and use thereof
TWI757773B (zh) * 2019-06-28 2022-03-11 瑞士商愛爾康公司 眼用組成物
BR112022002467A2 (pt) 2019-09-18 2022-07-19 Alcon Inc Insertos oculares de hidrogel suave embalados a úmido
CN114191378A (zh) * 2021-11-23 2022-03-18 温州医科大学附属眼视光医院 一种地夸磷索缓释凝胶及其制备方法与应用
AU2025233965A1 (en) 2024-03-04 2026-07-16 Alcon Inc. Carbamoylphenylboronic acid-containing acrylic monomers and uses thereof
KR20260082012A (ko) 2024-11-27 2026-06-04 허종욱 인공눈물의 효과 영향 및 안구 안정성 비교 연구 방법

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4136173A (en) * 1977-01-31 1979-01-23 American Home Products Corp. Mixed xanthan gum and locust beam gum therapeutic compositions
GB1593954A (en) * 1977-01-31 1981-07-22 American Home Prod Xanthan gum or locust bean gum topical therapeutic compositions
US5505953A (en) * 1992-05-06 1996-04-09 Alcon Laboratories, Inc. Use of borate-polyol complexes in ophthalmic compositions
DK0999854T3 (da) * 1997-07-29 2004-02-09 Alcon Mfg Ltd Omskiftelige viskoelastiske systemer, der indeholder galactomannanpolymerer og -borater
DE69818675T2 (de) * 1997-07-29 2004-07-29 Alcon Laboratories, Inc., Fort Worth Galaktomannanpolymere und borat enthaltende augenarzneimittel
IT1298758B1 (it) * 1998-03-19 2000-02-02 Angelini Ricerche Spa Soluzione umettante e lubrificante per uso oftalmico
TWI336257B (en) * 2003-06-13 2011-01-21 Alcon Inc Ophthalmic compositions containing a synergistic combination of three polymers
WO2005060933A1 (en) * 2003-12-11 2005-07-07 Alcon, Inc. Ophthalmic compositions containing a polysaccharide/borate gelling system
DE102006031500A1 (de) 2006-07-06 2008-04-17 Henkel Kgaa O/W-Emulsion
WO2008036855A2 (en) * 2006-09-21 2008-03-27 Alcon Research, Ltd. Self-preserved aqueous pharmaceutical compositions
US8119112B2 (en) * 2008-01-31 2012-02-21 Bausch & Lomb Incorporated Ophthalmic compositions with an amphoteric surfactant and hyaluronic acid
US9096819B2 (en) * 2008-01-31 2015-08-04 Bausch & Lomb Incorporated Ophthalmic compositions with an amphoteric surfactant and an anionic biopolymer
AR071834A1 (es) * 2008-04-26 2010-07-21 Alcon Res Ltd Sistema polimerico de lagrimas artificiales
NZ603345A (en) * 2010-05-05 2014-12-24 Alcon Res Ltd Stabilized ophthalmic galactomannan formulations

Similar Documents

Publication Publication Date Title
PE20110573A1 (es) Sistema de administracion de drogas que contiene progestina
JP2012525474A5 (enExample)
WO2014186742A3 (en) Anhydrous hydrogel composition
PE20130378A1 (es) Formulaciones de apixaban
MY161432A (en) Absorbent article
WO2015051054A3 (en) Benefit agent containing delivery particle based on styrene maleic anhydride copolymer
AR077411A2 (es) Forma de dosificacion farmaceutica solida, con lopinavir y ritonavir, y proceso para su preparacion.
CR9704A (es) Composicion farmaceutica de liberacion modificada, proceso de preparacion y metodo para emplear la misma.
NZ601200A (en) Pharmaceutical dosage forms comprising poly(epsilon-caprolactone)
AR044131A1 (es) Peliculas consumibles oralmente de disolucion rapida que contienen un almidon modificado para la mejora de la resistencia al calor y a la humedad
MX2009009463A (es) Preparacion de una pelicula de rapida disolucion/desintegracion que tiene una alta proporcion de ingrediente activo.
DOP2012000245A (es) Composiciones sólidas
WO2015099985A3 (en) Cationic materials and formulations for drug delivery
BR112013016662A2 (pt) composições biodegradáveis para administração de fármaco
MX2019007956A (es) Liberacion autorregulada de ingrediente farmaceutico activo.
MX341873B (es) Formulaciones solidas de retardo basadas en dispersiones solidas.
JP2013525493A5 (enExample)
WO2014116876A8 (en) Pharmaceutical formulation comprising an insoluble corticosteroid and a soluble corticosteroid
AR078283A1 (es) Formulaciones de suspension oral de dibenzazepina carboxamidas
AR094010A1 (es) Composiciones para el cuidado oral estables al peroxido
CO7071123A2 (es) Formulaciones basadas en dispersiones solidas
WO2015092811A3 (en) Oral films
PH12015500165A1 (en) Formulations and methods of manufacturing formulations for use in colonic evacuation
JP2013518051A5 (enExample)
JP2011513393A5 (enExample)